Coming full circle in diabetes mellitus: from complications to initiation

Brooke E Harcourt1, Sally A Penfold, Josephine M Forbes

  • 1Glycation and Diabetes Complications, Mater Medical Research Institute, Raymond Terrace, South Brisbane, QLD, Australia.

Insights

Diabetes mellitus (DM) management targets vascular complications. New research reveals that the same pathways driving complications also initiate DM, suggesting a unified mechanistic trigger from onset to chronic conditions.

Area of Science:

  • Endocrinology and Metabolism
  • Vascular Biology
  • Pathophysiology

Background:

  • Current diabetes mellitus (DM) management focuses on controlling hyperglycemia, blood pressure, and dyslipidemia to prevent vascular complications.
  • These interventions target pathological pathways contributing to diabetic nephropathy, retinopathy, neuropathy, and cardiovascular disease.
  • Emerging research suggests these pathways are also critical in the initial development of DM.

Purpose of the Study:

  • To review the mechanistic links between pathways involved in DM initiation and its chronic vascular complications.
  • To explore how common triggers contribute to both the onset and progression of diabetes mellitus.
  • To provide a comprehensive understanding of the full spectrum of DM pathogenesis.

Main Methods:

  • Literature review of recent research on diabetes mellitus pathogenesis and vascular complications.
  • Analysis of shared molecular and cellular pathways implicated in DM initiation and progression.
  • Synthesis of evidence linking insulin signaling, energy metabolism, post-translational modifications, and redox balance to DM.

Main Results:

  • Pathological pathways previously associated only with vascular complications are now recognized as key drivers of DM initiation.
  • Shared mechanisms, including impaired insulin signaling, altered cellular energy production, aberrant post-translational modifications, and redox imbalances, are implicated in both phases.
  • This indicates a cyclical nature of DM development, from onset through to chronic complications.

Conclusions:

  • The development of diabetes mellitus and its progression to chronic vascular complications share common mechanistic triggers.
  • Understanding these shared pathways offers new therapeutic targets for preventing both the onset and progression of DM.
  • A unified view of DM pathogenesis, from initiation to complications, is crucial for effective clinical management.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35